YS Biopharma (YSBPW) Institutional Ownership → Have You Seen Elon’s New A.I. Device? (Picture Inside) (From InvestorPlace) (Ad) Free YSBPW Stock Alerts $0.08 0.00 (0.00%) (As of 05/1/2024 ET) Add Compare Share Share OwnershipStock AnalysisChartCompetitorsFinancialsOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsFinancialsOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for YS Biopharma (NASDAQ:YSBPW)Number ofInstitutional Buyers(last 12 months)7Number ofInstitutional Sellers(last 12 months)0 Get YSBPW Insider Trade Alerts Want to know when executives and insiders are buying or selling YS Biopharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data YSBPW Institutional Buying and Selling by Quarter Ad Porter & CompanyTrump’s last act as President You’ve probably never heard of Executive Order #13972. Signed by President Trump just days before leaving office, it greenlit what could be the most revolutionary technology of the decade… yet it has nothing to do with AI, blockchain, or mRNA vaccines. For the full story, click here. YS Biopharma Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/16/2023 Snow Lake Management LP500,000$78K0.0%N/A0.000% 5/12/2023BFAM Partners Cayman Ltd550,000$86K0.1%N/A0.000% 5/12/2023Finepoint Capital LP489,999$76K0.0%N/A0.000% 5/11/2023Highbridge Capital Management LLC538,632$84K0.0%N/A0.000% 5/11/2023Athos Capital Ltd149,999$240K0.2%N/A0.000% 5/10/2023Valliance Asset Management Ltd750,000$117K0.2%N/A0.000% 5/5/2023Segantii Capital Management Ltd200,000$320K0.0%N/A0.000% (Data available from 1/1/2016 forward) YSBPW Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of YSBPW shares? During the previous two years, the following institutional investors and hedge funds held shares of YS Biopharma shares: Segantii Capital Management Ltd ($320K), Athos Capital Ltd ($240K), Valliance Asset Management Ltd ($117K), BFAM Partners Cayman Ltd ($86K), Highbridge Capital Management LLC ($84K), and Snow Lake Management LP ($78K), and Finepoint Capital LP ($76K).Learn more on YSBPW's institutional investors. Which institutional investors have been buying YS Biopharma stock? The following institutional investors have purchased YS Biopharma stock in the last 24 months: Valliance Asset Management Ltd ($750K), BFAM Partners Cayman Ltd ($550K), Highbridge Capital Management LLC ($538.63K), Snow Lake Management LP ($500K), Finepoint Capital LP ($490.00K), Segantii Capital Management Ltd ($200K), and Athos Capital Ltd ($150.00K). How much institutional buying is happening at YS Biopharma? Institutional investors have bought a total of 3,178,630 shares in the last 24 months. This purchase volume represents approximately $0.00 in transactions. Related Companies: Alpha Tau Medical Major Shareholders Apollomics Major Shareholders BriaCell Therapeutics Major Shareholders Cardio Diagnostics Major Shareholders Celularity Major Shareholders Fortress Biotech Major Shareholders Humacyte Major Shareholders Immatics Major Shareholders Jasper Therapeutics Major Shareholders NewAmsterdam Pharma Major Shareholders This page (NASDAQ:YSBPW) was last updated on 5/2/2024 by MarketBeat.com Staff From Our Partners😱 This phenomenon is smashing regular market gainsMillPubBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldHave You Seen Elon’s New A.I. Device? (Picture Inside)InvestorPlaceA.I. is a Tidal Wave - Here’s What to BuyChaikin AnalyticsYour bank is lying to you.MyBankTrackerDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsPOTUS in ‘25 Not Biden/Trump, ButThe Freeport SocietyForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill Publishing Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding YS Biopharma Co., Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
